AKT mediates actinomycin D-induced p53 expression

Citations Over TimeTop 11% of 2014 papers

Abstract

At high cytotoxic concentrations, actinomycin D (ActD) blocks transcription, decreasing levels of MDM2 and thus causing p53 stabilization. At low cytostatic concentrations, ActD causes ribosomal stress, which decreases MDM2 activity, resulting in p53 stabilization and activation. ActD can thus be used for p53-based cyclotherapy. We analyzed pathways mediating ActD-induced p53 expression. Inhibitors (LY294002, wortmannin, and deguelin) of phosphatidylinositol 3-kinases (PI3K) and AKT, but not inhibitors of MEK1/2, JNK, and p38-MAPK abolished the ActD-induced p53 expression in diverse cell types. RNA interference further supported these results. When AKT was downregulated by small hairpin RNA-AKTs, ActD-induced p53 expression was significantly decreased. ActD caused AKT phosphorylation at Ser473, indicating full activation of AKT. The potential for cancer therapy is discussed.

Related Papers

• → Distinct signaling mechanisms activate the target of rapamycin in response to different B‐cell stimuli(2007)80 cited
• → The phosphatidylinositol 3‐kinase inhibitor LY294002 potently blocks Kv currents via a direct mechanism(2003)78 cited
• → LY294002 inhibits LPS-induced NO production through a inhibition of NF-κB activation: independent mechanism of phosphatidylinositol 3-kinase(2005)62 cited
• → Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway(2014)17 cited
• → B7-H4-mediated immunoresistance is supressed by PI3K/Akt/mTOR pathway inhibitors(2016)2 cited